[1] Kathuria S,Arora S,Ramesh V.Sjögren-Larsson syndrome: importance of early diagnosis and aggressive physiotherapy[J].Dermatol Online J,2012, 15,18(9):11. [2] Fuijkschot J,Theelen T,Seyger MM,et al.Sjögren-Larsson syndrome in clinical practice[J].J Inherit Metab Dis,2012,35(6):955-962. [3] Ganemo A,Jagell S,Vahlquist A.Sjögren-larsson syndrome:a study of clinical symptoms and dermatological treatment in 34 Swedish patients[J].Acta Derm Venereol, 2009,89(1): 68-73. [4] Sanabria MR,Coco RM.Sjögren-larsson syndrome[J].Ophthalmology, 2011,118(10):2101-2012. [5] Sarret C,Rigal M,Vaurs-Barrière C,et al.Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort[J].J Neurol Sci,2012,312(1/2):123-126. [6] Nakayama M,Távora DG,Alvim TC,et al.MRI and 1H-MRS findings of three patients with Sjögren-Larsson syndrome[J].Arq Neuropsiquiatr,2006,64(2B):398-401. [7] Lacour M.Update on Sjögren-Larsson syndrome[J].Dermatology,1996,193(2):77-82. [8] Willemsen MA,Van Der Graff M,Van Der Knaap MS,et al.MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome:characterization of the leukoencephalopathy[J].AJNR Am J Neuroradiol,2004,25(4):649-657. [9] Pirgon O,Avdin K,Atabek ME.Proton magnetic resonance spectroscopy findings and clinical effects of montelukast sodium in a case with Sjögren-Larsson syndrome[J].J Child Neurol,2006,21(12):1092-1095. [10] Aoki N,Suzuki H,Ito K,et al.A novel point mutation of the FALDH gene in a Japanese family with Sjögren-Larsson syndrome[J].J Invest Dermatol,2000,114(5):1065-1066. [11] Kelson TL, Secor McVoy JR, Rizzo WB.Human liver fatty aldehyde dehydrogenase:microsomal localization,purification,and biochemical characterization[J].Biochim Biophys Acta,1997,1335 (1/2):99-110. [12] Rizzo WB.Sjogren–Larsson syndrome:molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency[J].Mol Genet Metab,2007,90(1):1-9. [13] Gordon N.Sjögren-Larsson syndrome[J].Dev Med Child Neurol,2007,49(2):152-154. |